Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells - PubMed (original) (raw)
. 1994 May 1;57(3):406-12.
doi: 10.1002/ijc.2910570319.
Affiliations
- PMID: 8169003
- DOI: 10.1002/ijc.2910570319
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells
H C Wu et al. Int J Cancer. 1994.
Abstract
A model of human prostate cancer was established to study cellular interaction between prostate cancer and bone stroma in vivo. In this model, subcutaneous co-injection of 2 non-tumorigenic human cell lines--LNCaP, a prostate cancer cell line, and MS, a bone stromal cell-line--into intact adult male mice resulted in formation of carcinomas that secreted prostate-specific antigen (PSA), a clinically useful human serum prostate cancer marker. In castrated hosts, upon cellular interaction with bone fibroblasts, we observed the progression of these tumors from an androgen-dependent (AD) to an androgen-independent state (AI). We derived 4 LNCaP cell sublines from the chimeric LNCaP/MS tumors: the M subline from intact hosts and the C4, C4-2 and C5 sublines from castrated hosts. The LNCaP sublines had chromosomal markers similar to those of the parental LNCaP cells and distinctly different from those of the MS bone stromal cell line. Although the parental and derived cell lines expressed similar steady-state levels of ornithine decarboxylase transcript, the sublines expressed 5- to 10-fold higher basal steady-state levels of PSA transcript than did the parental LNCaP cell line. The LNCaP sublines formed 13- to 26-fold more soft-agar colonies than the parental LNCaP cell line. The sublines became tumorigenic, yielding an incidence of tumors in intact athymic mice of 7-75%. The LNCaP sublines C4 and C5 (but not the parental and M cell line) formed tumors in castrated hosts when co-injected with bone fibroblasts. A second-generation LNCaP subline, C4-2, was derived from a chimeric tumor induced by co-inoculating castrated mouse with C4 cells and MS cells. We found that C4-2 subline was tumorigenic when inoculated into castrated hosts in the absence of inductive fibroblasts. Moreover, C4-2 was the only subline capable of forming soft-agar colonies when cultured in serum-free medium. In comparison with the parental LNCaP cells, the C4-2 subline expressed lower steady-state levels of androgen receptor (AR) protein and mRNA transcript and lost its androgen responsiveness in vitro. Our results suggest that certain genetic traits of prostate cancer cells may be selected or altered through an "adaptive" mechanism that involves cellular interaction with the bone stromal cells.
Similar articles
- LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. Thalmann GN, et al. Prostate. 2000 Jul 1;44(2):91-103 Jul 1;44(2). doi: 10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l. Prostate. 2000. PMID: 10881018 - Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Thalmann GN, et al. Cancer Res. 1994 May 15;54(10):2577-81. Cancer Res. 1994. PMID: 8168083 - Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW. Thalmann GN, et al. J Natl Cancer Inst. 1996 Jun 19;88(12):794-801. doi: 10.1093/jnci/88.12.794. J Natl Cancer Inst. 1996. PMID: 8637045 - Human prostate cancer progression models and therapeutic intervention.
Chung LW, Kao C, Sikes RA, Zhau HE. Chung LW, et al. Hinyokika Kiyo. 1997 Nov;43(11):815-20. Hinyokika Kiyo. 1997. PMID: 9436028 Review. - The role of stromal-epithelial interaction in normal and malignant growth.
Chung LW. Chung LW. Cancer Surv. 1995;23:33-42. Cancer Surv. 1995. PMID: 7621472 Review.
Cited by
- JAG1 Intracellular Domain Enhances AR Expression and Signaling and Promotes Stem-like Properties in Prostate Cancer Cells.
Tran TT, Lee K. Tran TT, et al. Cancers (Basel). 2022 Nov 21;14(22):5714. doi: 10.3390/cancers14225714. Cancers (Basel). 2022. PMID: 36428807 Free PMC article. - Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy.
Mitra R, Chao O, Urasaki Y, Goodman OB, Le TT. Mitra R, et al. BMC Cancer. 2012 Nov 21;12:540. doi: 10.1186/1471-2407-12-540. BMC Cancer. 2012. PMID: 23171028 Free PMC article. - Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer.
Narizhneva NV, Tararova ND, Ryabokon P, Shyshynova I, Prokvolit A, Komarov PG, Purmal AA, Gudkov AV, Gurova KV. Narizhneva NV, et al. Cell Cycle. 2009 Dec 15;8(24):4155-67. doi: 10.4161/cc.8.24.10316. Epub 2009 Dec 13. Cell Cycle. 2009. PMID: 19946220 Free PMC article. - Cancer-stromal cell fusion as revealed by fluorescence protein tracking.
Wang R, Lewis MS, Lyu J, Zhau HE, Pandol SJ, Chung LWK. Wang R, et al. Prostate. 2020 Feb;80(3):274-283. doi: 10.1002/pros.23941. Epub 2019 Dec 17. Prostate. 2020. PMID: 31846114 Free PMC article. - Role of prostate and bone stromal cells on prostate cancer progression.
Karkampouna S, Kruithof-de Julio M, Thalmann GN. Karkampouna S, et al. Am J Clin Exp Urol. 2022 Jun 15;10(3):180-187. eCollection 2022. Am J Clin Exp Urol. 2022. PMID: 35874291 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous